Tenecteplase for stroke patients who recently took blood thinners
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests if the clot-busting drug tenecteplase is safe and effective for people having an ischemic stroke who have recently taken blood thinners (DOACs). If you qualify, you may receive either tenecteplase or a placebo within 24 hours of your last known well time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are having an ischemic stroke (a clot blocks blood flow to part of your brain).
- You have taken a type of blood thinner called a DOAC (like apixaban, rivaroxaban, dabigatran, or edoxaban) within the last 48 hours, or you are on a DOAC but don't know when you last took it.
- You can start study treatment within 4.5 hours of when you were last seen normal, or within 4.5 to 24 hours if brain imaging shows a mismatch (meaning there's still salvageable brain tissue).
- Your stroke symptoms are moderate to moderately severe (NIHSS score 4-25), or you have a disabling stroke even with a lower score.
- You have not had any brain bleeding, recent major surgery, severe trauma, or active bleeding. You also must not be pregnant or have certain uncontrolled medical conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medication called rhTNK-tPA for treating acute ischemic stroke (a clot in the brain) up to 24 hours after symptom onset. The study uses simplified imaging to determine eligibility and aims to help patients recover better outcomes.
This trial tests whether a clot-busting drug called tenecteplase works safely in people having a stroke who are already taking certain blood-thinning medications (like apixaban or rivaroxaban). The goal is to see if it can restore blood flow to the brain better than current treatments.
This trial tests a clot-dissolving medicine called tenecteplase for people who had a stroke more than 4.5 hours ago. It may help you recover if given later than usual.
This trial tests whether tenecteplase (a clot-busting medication) can help patients who have had a stroke within 4.5 to 9 hours and show a specific pattern on brain MRI called DWI-FLAIR mismatch, which suggests the brain tissue may still be salvageable.
This trial tests a clot-dissolving medication called rhTNK-tPA for people who had a stroke 4.5 to 24 hours ago. It aims to help those with certain types of blockages in the brain who are still having moderate to severe symptoms.
This trial tests if the clot-busting drug tenecteplase can help people who have a stroke with an unknown start time (like waking up with symptoms) and cannot get an advanced brain scan. It aims to see if treatment within 3 hours of noticing symptoms is safe and effective.
Hear when a new Acute Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.